r.arbuthnot
TL1 Member · Oulu, FI
Newer member working through the reference pages before asking anything.
Joined 17 January 2025 · last posted 7d
23Posts here
1Topics
1Solutions
96Likes received
180Likes given
12Badges
101Days visited
1.2kPosts read
Most-liked posts
-
Journal club: the retatrutide phase 2 obesity paper Replied, post #4 · Evidence › Journal club · 13 Jul 2025 · 32 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #18 · Compounds › Secretagogues & GH axis · 6 Jun 2026 · 27 likes This follows post #15 rather than contradicting it. Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #21 · Practice › Reconstitution · 23 Feb 2025 · 21 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #64 · Analytics › Impurities & related substances · 10 Jul 2026 · 20 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #54 · Analytics › Home & field testing · 21 Jul 2026 · 19 likes On post #50 — agreed on the reasoning, with one qualification. Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at…
-
Coming back to: Getting a referral rather than a refusal Replied, post #60 · Clinical › Prescriber conversations · 12 Jun 2025 · 14 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| First Reply | bronze | 18 Jan 2025 |
| Basic User | bronze | 20 Jan 2025 |
| Read the Guidelines | bronze | 21 Jan 2025 |
| First Topic | bronze | 30 Jan 2025 |
| Welcome | bronze | 3 Feb 2025 |
| First Link | bronze | 13 Feb 2025 |
| First Quote | bronze | 16 Feb 2025 |
| Asked Well | bronze | 20 Feb 2025 |
| First Solution | bronze | 24 Feb 2025 |
| Nice Post | bronze | 31 Mar 2025 |
| Good Post | silver | 8 Jun 2025 |
| Anniversary | silver | 17 Jan 2026 |